First Read First Tracks Biotherapeutics Inc: Comp CD122 data further validates strong pot‘l for TRAX - Hosting mgmt at noon ET to discuss

Research evidence excerpt

First Read First Tracks Biotherapeutics Inc: Comp CD122 data further validates strong pot‘l for TRAX - Hosting mgmt at noon ET to discuss

alt

für Finanzdienstleistungsaufsicht, "BaFin") and supervised jointly by the European Central Bank, the German Central Bank (Deutsche Bundesbank) and BaFin, to which this

publication has not been submitted for approval. Hong Kong SAR: This publication is distributed to clients of UBS AG Hong Kong Branch by UBS AG Hong Kong Branch, a

licensed bank under the Hong Kong Banking Ordinance and a registered institution under the Securities and Futures Ordinance. UBS AG Hong Kong Branch is incorporated

in Switzerland with limited liability. The contents of this material have not been reviewed by any regulatory authority in Hong Kong. India: UBS Securities India Private Ltd.

(Corporate Identity Number U67120MH1996PTC097299) 2/F, 3 North Avenue, Maker Maxity, Bandra Kurla Complex, Bandra (East), Mumbai (India) 400051. Phone:

+912261556000. It provides brokerage services bearing SEBI Registration Number: INZ000259830; Merchant Banking services bearing SEBI Registration Number:

INM000013101 and Research Analyst services bearing SEBI Registration Number: INH000001204. Name of Compliance Officer Mr. Parameshwaran Shivaramakrishnan,

Phone: +912261556151, Email: parameshwaran.s@ubs.com, Name of Grievance Officer Parameshwaran Shivaramakrishnan, Phone: +912261556151, Email: ol-ubs-sec-

compliance@ubs.com. Registration granted by SEBI, and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to

investors. UBS AG, its affiliates or subsidiaries may have debt holdings or positions in the subject Indian company/companies. UBS AG, its affiliates or subsidiaries may have

financial interests (e.g.